Central Barangaroo Development
Sector: Hotel • Location: Sydney, New South Wales, Australia
Source: Property Council Australia
Aqualand has received approval to develop a new living and lifestyle precinct at Central Barangaroo, which will include residential, retail, hospitality, and community spaces, along with public open spaces and parkland.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | Planned |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | Aqualand has received approval to develop a new living and lifestyle precinct at Central Barangaroo, which will include residential, retail, hospitality, and community spaces, along with public open spaces and parkland. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |
More Hotel projects in Australia
- Lord Howe Island Hybrid Renewable Energy System
- Rottnest Island Water and Renewable Energy Nexus (WREN) Project
- Seqirus’ Influenza Vaccine Manufacturing Facility, Melbourne
- AstraZeneca’s Manufacturing Facility, North Ryde, Sydney
- BioCina’s Biologics Manufacturing Facility, Adelaide, Australia
- Lowy Cancer Research Institute
- Vaxxas Biomedical Manufacturing Facility, Australia
- CSL Recombinant Proteins Production Plant, Melbourne, Australia
